Several medical technology companies are expecting tariff hits, with some, like Boston Scientific, anticipating a $200M impact, while others, such as J&J, expect a larger tariff charge of $400M. Despite these expectations, some companies, including Boston Scientific, are raising their guidance, while others, like Stryker, are lowering their earnings forecasts. The impact of tariffs on these companies varies, with some, such as Siemens Healthineers, reporting a reduced tariff impact after trade talks.